XRTX
XRTX
NASDAQ · Pharmaceuticals

Xortx Therapeutics Inc

$0.91
-0.01 (-1.09%)
As of Nov 6, 10:27 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +4,585.7% upside
Low Target $28.32
Average Target $42.64
High Target $47.79
Current Price $0.91
Current
$0.91
Target
$42.64
$28.32 $42.64 avg $47.79
Scenario Analysis
Bear Case
$28.32
3,012.1%
Low target
Base Case
$42.64
+4,585.7%
Avg target
Bull Case
$47.79
+5,151.6%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.83
-81.2% from high
52-Week Low
$2.42
+-62.4% from low
Target vs 52W High
$42.64
+782.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%